Q/C Technologies, Inc. SEC filings QCLS

Q/C Technologies, Inc. has 604 filings in SEC EDGAR's recent list, going back to Mar 23, 2005. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 18, 2026 (material agreement, officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
10-Q Quarterly report Nov 19, 2025 Sep 30, 2025
10-Q Quarterly report Aug 19, 2025 Jun 30, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
10-Q Quarterly report Aug 19, 2024 Jun 30, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
10-Q Quarterly report Nov 14, 2023 Sep 30, 2023
10-Q Quarterly report Aug 14, 2023 Jun 30, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
10-Q Quarterly report Nov 10, 2022 Sep 30, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
10-Q Quarterly report May 16, 2022 Mar 31, 2022
10-Q/A Amended quarterly report Nov 15, 2021 Sep 30, 2021
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
10-Q Quarterly report Aug 16, 2021 Jun 30, 2021
10-Q Quarterly report May 18, 2021 Mar 31, 2021
10-Q Quarterly report Nov 16, 2020 Sep 30, 2020
10-Q Quarterly report Aug 14, 2020 Jun 30, 2020
10-Q Quarterly report May 15, 2020 Mar 31, 2020
10-Q Quarterly report Nov 14, 2019 Sep 30, 2019
10-Q Quarterly report Aug 14, 2019 Jun 30, 2019
10-Q Quarterly report May 20, 2019 Mar 31, 2019
10-Q Quarterly report Nov 14, 2018 Sep 30, 2018
10-Q Quarterly report Aug 14, 2018 Jun 30, 2018
10-Q Quarterly report Jul 13, 2018 Mar 31, 2018
10-Q/A Amended quarterly report Jul 13, 2018 Sep 30, 2017
10-Q/A Amended quarterly report Jul 13, 2018 Jun 30, 2017
10-Q Quarterly report Nov 14, 2017 Sep 30, 2017
10-Q Quarterly report Aug 14, 2017 Jun 30, 2017
10-Q Quarterly report May 15, 2017 Mar 31, 2017
10-Q Quarterly report Nov 14, 2016 Sep 30, 2016
10-Q Quarterly report Aug 11, 2016 Jun 30, 2016
10-Q Quarterly report May 12, 2016 Mar 31, 2016
10-Q Quarterly report Nov 13, 2015 Sep 30, 2015
10-Q Quarterly report Aug 18, 2015 Jun 30, 2015
10-Q Quarterly report May 14, 2015 Mar 31, 2015
10-Q Quarterly report Nov 13, 2014 Sep 30, 2014
10-Q Quarterly report Aug 12, 2014 Jun 30, 2014
10-Q Quarterly report May 14, 2014 Mar 31, 2014

Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
QCLS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1321834
Former names
Q/C TECHNOLOGIES, INC. (until Oct 2, 2026); TNF Pharmaceuticals, Inc. (until Sep 10, 2025); MyMD Pharmaceuticals, Inc. (until Jul 1, 2024); Akers Biosciences, Inc. (until Apr 16, 2021); Akers Biosciences Inc (until Apr 11, 2017)

Other In Vitro & In Vivo Diagnostic Substances companies

All 21 In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.